- Patent Title: Use of mannuronic diacid composition in treatment of inflammation
-
Application No.: US17256854Application Date: 2019-06-28
-
Publication No.: US11406659B2Publication Date: 2022-08-09
- Inventor: Meiyu Geng , Xianliang Xin , Zhenqing Zhang , Jian Ding
- Applicant: GREEN VALLEY (SHANGHAI) PHARMACEUTICALS CO., LTD. , SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES
- Applicant Address: CN Shanghai; CN Shanghai
- Assignee: GREEN VALLEY (SHANGHAI) PHARMACEUTICALS CO., LTD.,SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES
- Current Assignee: GREEN VALLEY (SHANGHAI) PHARMACEUTICALS CO., LTD.,SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES
- Current Assignee Address: CN Shanghai; CN Shanghai
- Agency: McCarter & English, LLP
- Agent Wei Song; Sudheer Chava
- Priority: CN201810721276.7 20180629
- International Application: PCT/CN2019/093656 WO 20190628
- International Announcement: WO2020/001611 WO 20200102
- Main IPC: A61K31/734
- IPC: A61K31/734 ; A61K31/7016 ; A61K31/702 ; A61P37/06 ; A61K31/7012
Abstract:
The present invention relates to the use of mannuronic diacid oligosaccharide composition in the treatment of inflammation.
Public/Granted literature
- US20210275570A1 USE OF MANNURONIC DIACID COMPOSITION IN TREATMENT OF INFLAMMATION Public/Granted day:2021-09-09
Information query
